The DOI matches its Crossref record; 420 of the 420 references it cites were found in a registry or an index.
Natural product and natural product derived drugs in clinical trials
Abstract
The 25 Natural Product (NP)-derived drugs launched since 2008 and the 100 NP-derived compounds and 33 Antibody Drug Conjugates (ADCs) in clinical trials or in registration at the end of 2013 are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–420 of 420
The year's new drugs & biologics, 2010
Graul, A., & Cruces, E. (2011) · Drugs of today · doi:10.1358/dot.2011.47.1.1587820 · Cited by 17
Butler, D. L., Chen, D., O’Dwyer, K., Lewandowski, T. F., Aubart, K. M., & Zalacaín, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-13 · Cited by 17
Eitzinger, C., Ehrlenbach, S., Lindner, H., Kremser, L., Gottardi, W., Debabov, D. V., Anderson, M., Nagl, M., & Orth‐Höller, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047105 · Cited by 16
CCLI.—Inositol and some of its isomerides
Müller, H. (1912) · Journal of the Chemical Society Transactions · doi:10.1039/ct9120102383 · Cited by 15
Studies on the Mechanism of Telavancin Decreased Susceptibility in a Laboratory-Derived Mutant
Song, Y., Lunde, C. S., Benton, B. M., & Wilkinson, B. J. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0195 · Cited by 15
Opioid receptor blocker shows promise in Phase II depression trial
Harrison, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4028 · Cited by 15
Visani, G., & Isidori, A. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.850491 · Cited by 15
Shazly, A., & Afifi, A. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.13 · Cited by 15
Szepesházi, K., Schally, A. V., Block, N. L., Halmos, G., Nadji, M., Szalontay, L., Vidaurre, I., Abi-Chaker, A. M., & Rick, F. G. (2013) · Oncotarget · doi:10.18632/oncotarget.1044 · Cited by 14
Yonesu, K., Kubota, K., Tamura, M., Inaba, S., Honda, T., Yahara, C., Watanabe, N., Matsuoka, T., & Nara, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217299 · Cited by 14
Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206
Sanchez, E., Li, M., Wang, C., Nichols, C. M., Li, J., Chen, H., & Berenson, J. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3130 · Cited by 14
Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
Thakur, A. B., Lum, L. G., Schalk, D. L., Azmi, A. S., Banerjee, S., Sarkar, F. H., & Mohommad, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047520 · Cited by 13
The Year's New Drugs & Biologics, 2011
Graul, A., Cruces, E., Dulsat, C., Arias, E., & Stringer, M. (2012) · Drugs of today · doi:10.1358/dot.2012.48.1.1769676 · Cited by 13
The year's new drugs & biologics - 2008
Graul, A. I., Revel, L., Barrionuevo, M., Cruces, E., Rosa, E., Verges, C., Lupone, B., Diaz, N., & Castaner, R. M. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.1.1303754 · Cited by 12
The year's new drugs and biologics--2007.
Graul, A., Prous, J., Barrionuevo, M., Bozzo, J., Castaner, R. M., Cruces, E., Revel, L., Rosa, E., Serradell, N., & Sorbera, L. A. (2008) · PubMed · Cited by 11
Omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia
Narayanan, V., Gutman, J. A., Pollyea, D. A., & Jimeno, A. (2013) · Drugs of today · doi:10.1358/dot.2013.49.7.1980495 · Cited by 10
Toderika, Y., & Ferguson, N. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000011 · Cited by 9
PKCθ: a new target for selective immunosuppression
Altman, A., & Kong, K. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.8 · Cited by 8
Drugs in Development for Opioid-Induced Constipation
Sprawls, K. S., Spierings, E., & Tran, D. P. (2012) · InTech eBooks · doi:10.5772/30377 · Cited by 4
Pharmacotherapy of Pompe disease
Parenti, G., & Andria, G. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.795855 · Cited by 1
Cited by
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
Anand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
Metadata
- Authors
- Butler, M. S., Robertson, A. A. B., & Cooper, M. A.
- Venue
- Nat. Prod. Rep.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 31
- Issue
- 11
- Pages
- 1612-1661
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2088629793
- Cited by
- 602
- References
- 420
- FWCI
- 36.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.